Smith & Nephew plc (SN.) Ordinary USD0.20
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
London close: Stocks finish firmer ahead of Easter break
28 March 2024 16:08
(Sharecast News) - London's equity markets closed higher on Thursday ahead of the Easter break, despite lingering concerns over the UK's recessionary status in the latter part of last year.
-
London close: Stocks little changed as investors look to US data
27 February 2024 16:05
(Sharecast News) - London's equity markets closed with a subdued performance on Tuesday, after a mixed but largely flat session trend as investors exercised caution ahead of US inflation figures later...
-
Smith & Nephew revenue growth tops full-year forecasts
27 February 2024 07:22
(Sharecast News) - Medical device giant Smith & Nephew reported fourth-quarter revenue of $1.46bn on Tuesday, marking a 6.4% increase on an underlying basis compared to the prior year.
-
RBC sees upside risk to Q4 results at Smith & Nephew
12 February 2024 08:39
(Sharecast News) - RBC Capital Markets has reiterated its 'outperform' rating on Smith & Nephew ahead of the medical devices giant's fourth-quarter results later this month, saying it sees...
-
London close: Stocks slip after surprise jump in UK inflation
17 January 2024 15:03
(Sharecast News) - London's financial markets experienced a downturn on Wednesday, as a surprising increase in UK inflation and sluggish Chinese GDP growth impacted investor sentiment.
-
BofA Merrill Lynch lifts Smith & Nephew price target
17 January 2024 12:46
(Sharecast News) - Bank of America Merrill Lynch upped its price target on Smith & Nephew on Wednesday to 1,320p from 1,180p.
-
BofA Merrill Lynch lifts Smith & Nephew price target
17 January 2024 12:46
(Sharecast News) - Bank of America Merrill Lynch upped its price target on Smith & Nephew on Wednesday to 1,320p from 1,180p.
-
Smith & Nephew wraps up $330m purchase of Israeli medtech firm CartiHeal
10 January 2024 07:27
(Sharecast News) - Medtech giant Smith + Nephew has completed the acquisition of CartiHeal, the developer of novel sports medicine technology Agili-C, which targets cartilage regeneration in the knee.
-
Smith & Nephew names new audit committee lead
6 December 2023 07:47
(Sharecast News) - Smith & Nephew has announced that non-executive director Rick Medlock has decided to step down after three years at the medical technology group.
-
Goldman starts Smith & Nephew at 'buy', cites improving fundamentals
10 November 2023 09:36
(Sharecast News) - Goldman Sachs initiated coverage of Smith & Nephew on Friday with a 'buy' rating and 1,400p price target, as it pointed to improving fundamentals and an undemanding valuation.
-
JPMorgan upgrades Smith & Nephew, says recent de-rating 'overdone'
3 November 2023 09:19
(Sharecast News) - JPMorgan Cazenove upgraded Smith & Nephew to 'overweight' from 'neutral' on Friday as it argued the recent de-rating was overdone.
-
London close: Stocks rise as BoE keeps rates steady
2 November 2023 15:12
(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.
Company announcements Announcements
-
Timing of Smith+Nephew Q1 2024 Trading Report
23 April 2024 09:46
Smith & Nephew
-
Total Voting Rights
2 April 2024 13:43
Smith & Nephew
-
Director/PDMR Shareholding
2 April 2024 13:19
Smith & Nephew
-
Directorate Change
28 March 2024 07:00
Smith & Nephew
-
SMITH+NEPHEW PRICES USD BOND ISSUE
14 March 2024 07:00
Smith & Nephew
-
Director/PDMR Shareholding
13 March 2024 16:03
Smith & Nephew
-
Director/PDMR Shareholding
11 March 2024 18:20
Smith & Nephew
-
Total Voting Rights
1 March 2024 11:26
Smith & Nephew
-
Final Results
27 February 2024 07:00
Smith & Nephew
-
Change in Director Details
23 February 2024 07:00
Smith & Nephew
-
Block listing Interim Review
14 February 2024 13:47
Smith & Nephew
-
Total Voting Rights
1 February 2024 14:12
Smith & Nephew
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.